Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT04548817
Conditions
Cutaneous Melanocytic Neoplasm
Large Cutaneous Melanocytic Nevi
Neurocutaneous Melanocytosis
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Cutaneous Melanocytic Neoplasm
Large Cutaneous Melanocytic Nevi
Neurocutaneous Melanocytosis
Study ID
NCT04548817
Start date
Sep 3, 2020
Status verified date
Sep, 2025
Completion date
Sep 3, 2027
Anticipated
Primary completion date
Sep 3, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Arms
Neurocutaneous Melanocytosis
Primary outcome measure
Central contacts
Locations
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Recruiting
New York, New York, United States, 10065
Contacts
Yasmin Khakoo, MD
212-639-8292Sponsor
Memorial Sloan Kettering Cancer Center
Last update posted
Sep 30, 2025
Last verified
Sep, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-09-30.